Statements in MD&A are consistent with what was announced at the AGM regarding SSRA and trial timeline.

"The BETonMACE trial is expected to be complete by around the end of calendar 2018 with third party adjudication of all MACE events anticipated to be available within two months past trial completion. The topline results of the study will be made available shortly thereafter."

"It has been determined that a SSRA will no longer be performed given the BETonMACE trial is expected to be complete by around the end of calendar 2018 and that conducting such an analysis at this stage would offer no practical value and would also cause a statistical penalty in regards to final powering of the trial."